奥赛康10月22日获融资买入1360.95万元，融资余额2122.58万元

Core Insights - On October 22, Aosai Kang's stock increased by 0.93%, with a trading volume of 245 million yuan [1] - The company reported a financing buy amount of 13.61 million yuan and a net financing buy of 7.71 million yuan on the same day [1][2] - As of October 22, the total financing and securities lending balance for Aosai Kang was 21.23 million yuan, accounting for 0.12% of its market capitalization [2] Financial Performance - For the first half of 2025, Aosai Kang achieved a revenue of 1.007 billion yuan, representing a year-on-year growth of 9.20% [2] - The net profit attributable to the parent company was 160 million yuan, showing a significant year-on-year increase of 111.64% [2] Shareholder Information - As of September 30, the number of shareholders for Aosai Kang was 27,200, an increase of 35.87% compared to the previous period [2] - The average number of circulating shares per shareholder was 34,075, which decreased by 26.40% from the previous period [2] Dividend Distribution - Since its A-share listing, Aosai Kang has distributed a total of 721 million yuan in dividends, with 111 million yuan distributed over the past three years [3] Institutional Holdings - As of June 30, 2025, the sixth largest circulating shareholder was Yongying Medical Innovation Mixed Fund, holding 11.69 million shares as a new shareholder [3] - Other notable shareholders include Penghua Medical Technology Stock A and E Fund Healthcare Industry Mixed A, with slight reductions in their holdings [3]